A phase II study of constant‐infusion floxuridine for the treatment of metastatic renal cell carcinoma - Concepedia

Concepedia

Publication | Closed Access

A phase II study of constant‐infusion floxuridine for the treatment of metastatic renal cell carcinoma

15

Citations

9

References

1993

Year

Mary Wilkinson, John Frye, Eric J. Small, Alan P. Venook, Peter R. Carroll, Mary Lou Ernest, Robert Stagg

Abstract

Constant-infusion floxuridine is active against metastatic RCC and produces a response rate that appears to be comparable to that of circadian administration of floxuridine.

References

	Year	Citations
Prognostic Factors in Metastatic Renal Carcinoma John D. Maldazys, Jean B. deKernion The Journal of Urology	1986	363
Renal cell carcinoma: Survival and prognostic factors Mircea Golimbu, A. N. Tessler, Prashant Joshi, Urology UrologyGenitourinary CancerMedicineRenal Cell CarcinomaOncology	1986	310
Cigarette Smoking, Obesity, Diuretic Use, and Coffee Consumption as Risk Factors for Renal Cell Carcinoma<xref ref-type="fn" rid="FN1">2</xref> T M Mack, Rosemarie Hanisch, C Cicioni, JNCI Journal of the National Cancer Institute	1986	227
The natural history of renal carcinoma. A.W.S. Ritchie, G. D. Chisholm PubMed	1983	172
Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma. William J.M. Hrushesky, Reinhard von Roemeling, Rosellen Lanning, Journal of Clinical Oncology Surgical OncologyFudr Ia InfusionCircadian-shaped InfusionsPharmacotherapyTumor Biology	1990	118
Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer. Reinhard von Roemeling, William J.M. Hrushesky Journal of Clinical Oncology Widespread CancerFudr InfusionPharmacotherapyMetronomic ChemotherapyOxidative Stress	1989	100
Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump B Damascelli, Alfonso Marchianò, Carlo Spreafico, Cancer Pump FunctionUrologySurgical OncologyAvailable TreatmentGenitourinary Cancer	1990	47
Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell carcinoma. Hrushesky Wj, Von Roemeling R, Fraley Ee, PubMed UrologyGenitourinary CancerMedicineCancer ManagementPharmacology	1988	25
More evidence for circadian rhythm effects in cancer chemotherapy: the fluoropyrimidine story. Hrushesky Wj PubMed OncologyFluoropyrimidine StoryMore EvidenceMedicineCircadian Rhythm Effects	1990	12

Page 1